China’s famed respiratory disease expert Zhong Nanshang (photo) issued a new warning over the weekend about the vulnerabilities of Chinese COVID-19 vaccines that use so-called inactive agents and their ability to hold up against new variants.
Zhong acknowledged at a medical forum on Saturday that both Sinopharm and Sinovac vaccines showed reduced efficacy against the B.1.351 variant that was first detected in South Africa.
- Get a daily email packed with the latest China-Africa news and analysis.
- Read exclusive insights on the key trends shaping China-Africa relations.
- Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.